Display options
Cite
Harvey NC, Poole KE, Ralston SH, et al. Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Arch Osteoporos. 2022;17(1):12doi: 10.1007/s11657-021-01049-7.
Harvey, N. C., Poole, K. E., Ralston, S. H., McCloskey, E. V., Sangan, C. B., Wiggins, L., Jones, C., Gittoes, N., Compston, J. (2022). Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Archives of osteoporosis, 17(1), 12. https://doi.org/10.1007/s11657-021-01049-7
Harvey, Nicholas C, et al. "Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap." Archives of osteoporosis vol. 17,1 (2022): 12. doi: https://doi.org/10.1007/s11657-021-01049-7
Harvey NC, Poole KE, Ralston SH, McCloskey EV, Sangan CB, Wiggins L, Jones C, Gittoes N, Compston J. Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap. Arch Osteoporos. 2022 Jan 06;17(1):12. doi: 10.1007/s11657-021-01049-7. PMID: 34988772.
Copy Download .nbib Format: NLM
Share it on

Arch Osteoporos. 2022 Jan 06;17(1):12. doi: 10.1007/s11657-021-01049-7.

Towards a cure for osteoporosis: the UK Royal Osteoporosis Society (ROS) Osteoporosis Research Roadmap.

Archives of osteoporosis

Nicholas C Harvey, Kenneth E Poole, Stuart H Ralston, Eugene V McCloskey, Caroline B Sangan, Lauren Wiggins, Craig Jones, Neil Gittoes, Juliet Compston,

Affiliations

  1. MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK. [email protected].
  2. NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital, Southampton NHS Foundation Trust, Southampton, UK. [email protected].
  3. Metabolic Bone Disease Unit, Addenbrooke's Hospital, Cambridge, UK.
  4. Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  5. Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
  6. MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, Mellanby Centre for Musculoskeletal Research, University of Sheffield, Sheffield, UK.
  7. Royal Osteoporosis Society, Bath, UK.
  8. Centre for Endocrinology, Diabetes and Metabolism (CEDAM), University of Birmingham, Birmingham, UK.
  9. Department of Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.

PMID: 34988772 DOI: 10.1007/s11657-021-01049-7

[No abstract available.]

References

  1. Anon (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646–650 - PubMed
  2. van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517–522 - PubMed
  3. Curtis EM, van der Velde R, Moon RJ, van den Bergh JP, Geusens P, de Vries F, van Staa TP, Cooper C, Harvey NC (2016) Epidemiology of fractures in the United Kingdom 1988–2012: variation with age, sex, geography, ethnicity and socioeconomic status. Bone 87:19–26 - PubMed
  4. Harvey N, Dennison E, Cooper C (2010) Osteoporosis: impact on health and economics. Nat Rev Rheumatol 6:99–105 - PubMed
  5. Borgström F, Karlsson L, Ortsäter G et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59 - PubMed
  6. Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Willers C, Borgström F (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16:82 - PubMed
  7. Harvey NC, McCloskey EV, Mitchell PJ, Dawson-Hughes B, Pierroz DD, Reginster JY, Rizzoli R, Cooper C, Kanis JA (2017) Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int 28:1507–1529 - PubMed
  8. Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, Shane E (2017) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res 32:424–430 - PubMed
  9. Compston J (2020) Reducing the treatment gap in osteoporosis. Lancet Diabetes Endocrinol 8:7–9 - PubMed
  10. Harvey NCW, McCloskey EV, Rizzoli R, Kanis JA, Cooper C, Reginster J-Y (2019) Osteoporosis: treatment gaps and health economics. In: Huhtaniemi I, Martini L (eds) Encyclopedia of endocrine diseases, 2nd edn. Academic Press, Oxford, pp 288–295 - PubMed
  11. Conley RB, Adib G, Adler RA et al (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Orthop Trauma 34:e125–e141 - PubMed
  12. Tobias JH, Duncan EL, Kague E et al (2020) Opportunities and challenges in functional genomics research in osteoporosis: report from a workshop held by the Causes Working Group of the Osteoporosis and Bone Research Academy of the Royal Osteoporosis Society on October 5th 2020. Front Endocrinol 11:630875 - PubMed
  13. Aggarwal V, Maslen C, Abel RL et al (2021) Opportunistic diagnosis of osteoporosis, fragile bone strength and vertebral fractures from routine CT scans; a review of approved technology systems and pathways to implementation. Ther Adv Musculoskelet Dis 13:1759720x211024029 - PubMed
  14. Hardcastle SA (2021) Pregnancy and lactation associated osteoporosis. Calcif Tissue Int; Online ahead of print. - PubMed
  15. Morris JA, Kemp JP, Youlten SE et al (2019) An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet 51:258–266 - PubMed
  16. Zheng J, Maerz W, Gergei I et al (2019) Mendelian randomization analysis reveals a causal influence of circulating sclerostin levels on bone mineral density and fractures. J Bone Miner Res 34:1824–1836 - PubMed
  17. Oswald AJ, Berg K, Ralston SH, Riches PL (2019) Long-term effects of teriparatide followed by antiresorptive therapy on clinical outcomes in patients with severe spinal osteoporosis. Calcif Tissue Int 105:148–155 - PubMed
  18. Ohlsson C, Sjogren K (2018) Osteomicrobiology: a new cross-disciplinary research field. Calcif Tissue Int 102:426–432 - PubMed
  19. Sjogren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Backhed F, Ohlsson C (2012) The gut microbiota regulates bone mass in mice. J Bone Miner Res 27:1357–1367 - PubMed
  20. Li JY, Chassaing B, Tyagi AM et al (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126(6):2049–2063 - PubMed
  21. Das M, Cronin O, Keohane DM et al (2019) Gut microbiota alterations associated with reduced bone mineral density in older adults. Rheumatology (Oxford) 58(12):2295–2304 - PubMed
  22. Nilsson AG, Sundh D, Backhed F, Lorentzon M (2018) Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial. J Intern Med 284:307–317 - PubMed
  23. Xu M, Pirtskhalava T, Farr JN et al (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24:1246–1256 - PubMed
  24. Farr JN, Xu M, Weivoda MM et al (2017) Targeting cellular senescence prevents age-related bone loss in mice. Nat Med 23:1072–1079 - PubMed
  25. Adam S, Simon N, Steffen U et al (2020) JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function. Sci Transl Med 12(530):eaay4447 - PubMed
  26. Compston J, Cooper A, Cooper C et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12:43 - PubMed
  27. Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3–44 - PubMed
  28. Bromiley PA, Clark EM, Poole KE (2020) Computer-aided diagnostic systems for osteoporotic vertebral fracture detection: opportunities and challenges. J Bone Miner Res 35:2305–2306 - PubMed
  29. Wensing M, Grol R (2019) Knowledge translation in health: how implementation science could contribute more. BMC Med 17:88 - PubMed
  30. McCloskey E, Rathi J, Heijmans S et al (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32:251–259 - PubMed
  31. Fatoye F, Smith P, Gebrye T, Yeowell G (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9:e027049 - PubMed
  32. Javaid MK (2021) Efficacy and efficiency of fracture liaison services to reduce the risk of recurrent osteoporotic fractures. Aging Clin Exp Res 33:2061–2067 - PubMed
  33. Hawarden A, Jinks C, Mahmood W, Bullock L, Blackburn S, Gwilym S, Paskins Z (2020) Public priorities for osteoporosis and fracture research: results from a focus group study. Arch Osteoporos 15:89 - PubMed
  34. Paskins Z, Jinks C, Mahmood W, Jayakumar P, Sangan CB, Belcher J, Gwilym S (2017) Public priorities for osteoporosis and fracture research: results from a general population survey. Arch Osteoporos 12:45 - PubMed
  35. (2018) BROKEN BONES, BROKEN LIVES: A roadmap to solve the fragility fracture crisis in Europe. International Osteoporosis Foundation, Nyon - PubMed
  36. Yang TL, Shen H, Liu A, Dong SS, Zhang L, Deng FY, Zhao Q, Deng HW (2020) A road map for understanding molecular and genetic determinants of osteoporosis. Nat Rev Endocrinol 16:91–103 - PubMed

Publication Types